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OBJECTIVES Previous studies have documented that obstructive sleep
apnea (OSA) increases the incidence of hypertension, respiratory failure
and unexpected post-operative deaths during night in coronary artery
bypass grafting (CABG) patients. However, it lacks a prospective,
controlled study to conﬁrm thephenomenonobserved in clinical practice.
In the present study, our aimwas to investigate the effects of continuous
positive airway pressure on blood pressure and major adverse cardio-
vascular events (MACEs) in hypertensive patients with CABG and OSA.
METHODS We conducted a prospective, controlled study in 106 pa-
tients. The subjects received CPAP treatment were deﬁned as CPAP
group, whereas those refused to use CPAP were served as controls.
Blood pressure was measured by 24 h ambulatory blood pressure at
baseline and at the end of study. Patients were followed up for 5
years, and MACEs were analyzed.
RESULTS Ninety-ﬁve patients completed the study. CPAP group and
controls had similar characteristics at baseline. Compared with the
control group, the 24-h SBP in theCPAPgrouphad a signiﬁcant reduction
(Control: 145.2  8.5 mm Hgvs. CPAP: 140.4  7.3 mm Hg, P¼0.036; D:
6.5 mm Hg [95% CI, 1.7 to 8.3], P¼0.015), but the 24-h DBP had no sig-
niﬁcant difference. The rate of hypertension controlwas improved in the
CPAP treatment (CPAP, 78.0% vs. Control, 53.7%; P¼0.027). Compared
with controls, the proportion of non-dipping hypertension had a mark-
edly improvement in the CPAP group (Control, 42.5% vs. CPAP, 18.3%;
P¼0.032). MACEs in the CPAP group were signiﬁcantly lower than in the
control group (Control, 20.4% vs. CPAP, 10.9%; P¼0.024).
CONCLUSIONS Long-term application of CPAP in hypertensive pa-
tients with CABG and OSA receiving standardized antihypertensive
treatment, compared to controls, signiﬁcantly reduced 24-h SBP,
improved hypertension control and status of non-dipping hyperten-
sion, and decreased the MACEs.
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OBJECTIVES Mitral valve replacement procedures with either a
bioprosthetic or a mechanical valve are used to treat mitral ste-
nosis. This study aimed to evaluate the outcomes of these two
procedures.
METHODS A retrospective cohort study was performed on prospec-
tively collected data involving a total of 195 mitral stenosis patients
who have undergone mitral valve replacement with either bio-
prosthetic (n¼50) or mechanical (n¼145) valves in our institute from
1999 to 2012.
Data were analyzed for early and late mortality, NYHA functional
classes, pre- and post-operative echocardiographic ﬁndings, early and
late valve-related complications, and survival. Chi Square test, logistic
regression, Kaplan Meier curve, and dependent proportions tests were
some of the tests employed in the analysis.
RESULTS Out of 195 patients, 104 (53%) patients could be reached by
telephone calls for collecting long-term outcome information. Twelve
patients had late mortality, six in the bioprosthesis group and six in
the mechanical.
One patient had early perioperative mortality. The Late mortality
had signiﬁcant association with post-op stroke (P<0.001) and post-op
NYHA classes III and IV (P¼0.002). Post-op NYHA class was signiﬁ-
cantly associated with age (P¼0.003), pulmonary disease (P¼0.017),
mitral valve type (P¼0.011, mechanical valves better), hypertension
(P¼0.01), and post-op stroke (P¼0.017). NYHAclasses were signiﬁ-
cantly better after the replacement surgeries (P<0.001). Bioprosthetic
valves were signiﬁcantly associated with worse survival (P¼0.03),worse NYHA post-op (P¼0.011), and more re-operations (P¼0.006);
and borderline association with late mortality. Survival was signiﬁ-
cantly better with mechanical valves (P¼0.03).
CONCLUSIONS Mechanical mitral valve replacement in mitral ste-
nosis patients is associated with less late mortality, better NYHA
classes, less re-operation rate, and better survival as compared to
bioprosthetic mitral valve replacement. Stroke occurrence is associ-
ated with late mortality and worse NYHA classes.GW26-e1248
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OBJECTIVES Acute kidney injury (AKI) is common after surgery for
acute aortic dissection (AAD) and increases mortality. However, few
data exist on the clinical and prognostic relevance of early preopera-
tive AKI in patients with type A AAD. We aimed to determine the
incidence and predictors of preoperative AKI and the impact of AKI on
in-hospital outcomes in patients with type A AAD.
METHODS We retrospectively enrolled 178 patients admitted to our
hospital within 36 hours from symptom onset and receiving open
surgery for type A AAD. The patients were divided into no AKI and AKI
groups and staged with AKI severity according to the Kidney Disease:
Improving Global Outcomes (KDIGO) criteria before surgery.
RESULTS AKI occurred in 41 patients (23.0%). The incidence of in-
hospital complications was signiﬁcantly higher in patients with
preoperative AKI (41.5% vs 9.5%, p<0.001), including acute renal
failure (19.5% vs 2.2%, p<0.001) and renal infarction (7.3% vs 0,
p¼0.012), and it increased with AKI severity (ptrend<0.001). The
maximum levels of body temperature, white blood cell count, and
platelet count were signiﬁcantly correlated with maximum serum
creatinine level before surgery. Multivariate analysis indicated that
male sex, diastolic blood pressure on admission and bilateral renal
artery involvement were independent predictors of preoperative
AKI.
CONCLUSIONS Early AKI before surgery was common in patients
with type A AAD, and was associated with increased in-hospital
complications and enhanced inﬂammatory reaction. Male sex, dia-
stolic blood pressure on admission and bilateral renal artery
involvement were major risk factors for preoperative AKI.
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OBJECTIVES Acute kidney injury (AKI) frequently occurs after
catheter-based interventional procedures and increases mortality.
However, the implication of AKI before thoracic endovascular
aneurysm repair (TEVAR) of type B acute aortic dissection (AAD)
remains unclear. We aimed to determine the incidence, predictors,
and in-hospital outcomes of AKI before TEVAR in patients with type
B AAD.
METHODS Between 2009 and 2013, we evaluated retrospectively 76
patients who received TEVAR for type B AAD in our hospital within 36
hours from symptom onset. The patients were classiﬁed into no AKI
and AKI groups, and the severity of AKI was further staged according
to Kidney Disease: Improving Global Outcomes (KDIGO) criteria before
TEVAR.
